Skip to main content

. 1975 Mar 29;1(5960):735–736. doi: 10.1136/bmj.1.5960.735-c

Letter: Serum muramidase activity in untreated cancer.

W W Jedrzejczak, M Siekierzynski

PMCID: PMC1672735 PMID: 1125686

735

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Guerry D., 4th, Dale D. C., Omine M., Perry S., Wolff S. M. Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest. 1973 Dec;52(12):3220–3230. doi: 10.1172/JCI107522. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hansen N. E., Andersen V., Karle H. Plasma lysozyme in drug-induced and spontaneous cyclic neutropenia. Br J Haematol. 1973 Oct;25(4):485–495. doi: 10.1111/j.1365-2141.1973.tb01761.x. [DOI] [PubMed] [Google Scholar]
Park B. H., Fikrig S. M., Smithwick E. M. Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid. Lancet. 1968 Sep 7;2(7567):532–534. doi: 10.1016/s0140-6736(68)92406-9. [DOI] [PubMed] [Google Scholar]
Szmigielski S., Okninska A., Ostojska J., Moneta J. Serum lysozyme (muramidase) as functional test of granulopoiesis in the course of cytostatic therapy. Folia Haematol Int Mag Klin Morphol Blutforsch. 1974;101(6):935–941. [PubMed] [Google Scholar]

ACTIONS

RESOURCES